Sunitinib Mylan 12,5 mg cietās kapsulas 라트비아 - 라트비아어 - Zāļu valsts aģentūra

sunitinib mylan 12,5 mg cietās kapsulas

mylan ireland limited, ireland - sunitinibs - kapsula, cietā - 12,5 mg

Sunitinib Mylan 50 mg cietās kapsulas 라트비아 - 라트비아어 - Zāļu valsts aģentūra

sunitinib mylan 50 mg cietās kapsulas

mylan ireland limited, ireland - sunitinibs - kapsula, cietā - 50 mg

Sunitinib Accord 유럽 연합 - 라트비아어 - EMA (European Medicines Agency)

sunitinib accord

accord healthcare s.l.u. - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiski līdzekļi - gastrointestinal stromal tumour (gist)sunitinib accord is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sunitinib accord is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sunitinib accord is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours (pnet) with disease progression in adults.

Sunitinib Stada 12,5 mg cietās kapsulas 라트비아 - 라트비아어 - Zāļu valsts aģentūra

sunitinib stada 12,5 mg cietās kapsulas

stada arzneimittel ag, germany - sunitinibs - kapsula, cietā - 12,5 mg